TR200003498T2 - Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları - Google Patents

Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları

Info

Publication number
TR200003498T2
TR200003498T2 TR2000/03498T TR200003498T TR200003498T2 TR 200003498 T2 TR200003498 T2 TR 200003498T2 TR 2000/03498 T TR2000/03498 T TR 2000/03498T TR 200003498 T TR200003498 T TR 200003498T TR 200003498 T2 TR200003498 T2 TR 200003498T2
Authority
TR
Turkey
Prior art keywords
amino acid
acid sequence
provides
vaccines
binding protein
Prior art date
Application number
TR2000/03498T
Other languages
English (en)
Turkish (tr)
Inventor
I. Tuomanen Elaine
Robert Masure H.
M.Wizemann Theresa
Sydnor Johnson Leslie
Koenig Scott
Original Assignee
St. Jude Children's Research Hospital
Medimmune,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/056,019 external-priority patent/US6858706B2/en
Application filed by St. Jude Children's Research Hospital, Medimmune,Inc. filed Critical St. Jude Children's Research Hospital
Publication of TR200003498T2 publication Critical patent/TR200003498T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2000/03498T 1998-04-07 1999-04-07 Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları TR200003498T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Publications (1)

Publication Number Publication Date
TR200003498T2 true TR200003498T2 (tr) 2001-10-22

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03498T TR200003498T2 (tr) 1998-04-07 1999-04-07 Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları

Country Status (14)

Country Link
JP (1) JP4739521B2 (https=)
KR (1) KR100638503B1 (https=)
CN (1) CN1191851C (https=)
AU (2) AU3479699A (https=)
BR (1) BR9909910A (https=)
CA (1) CA2326388C (https=)
HU (1) HUP0102306A3 (https=)
IL (1) IL138939A0 (https=)
MX (1) MXPA00009899A (https=)
NO (1) NO20005081L (https=)
NZ (1) NZ507983A (https=)
PL (1) PL193132B1 (https=)
TR (1) TR200003498T2 (https=)
WO (1) WO1999051188A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
KR101515078B1 (ko) 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2690708A1 (en) 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine
ES2553113T3 (es) 2008-04-16 2015-12-04 Glaxosmithkline Biologicals S.A. Vacuna
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
CN103533953A (zh) 2011-05-17 2014-01-22 葛兰素史密丝克莱恩生物有限公司 针对肺炎链球菌的疫苗
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201711635D0 (en) 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
ES2262177T3 (es) * 1996-05-01 2006-11-16 The Rockefeller University Proteinas de union a colina para vacunas frente a neumococos.
JP4469026B2 (ja) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ,インコーポレイテッド Streptococcus pneumoniaeの抗原およびワクチン
JP2002503087A (ja) * 1996-11-12 2002-01-29 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ストレプトコッカス・ニューモニアのc3結合タンパク質
DE69942176D1 (de) * 1998-04-07 2010-05-06 Medimmune Llc Choline-bindende proteine derivate aus pneumokoken als impfstoff
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Also Published As

Publication number Publication date
BR9909910A (pt) 2002-01-15
NO20005081D0 (no) 2000-10-09
CA2326388C (en) 2014-02-04
CA2326388A1 (en) 1999-10-14
WO1999051188A3 (en) 2001-04-19
JP2002516662A (ja) 2002-06-11
AU3479699A (en) 1999-10-25
NO20005081L (no) 2000-12-06
AU764811B2 (en) 2003-08-28
NZ507983A (en) 2004-03-26
MXPA00009899A (es) 2002-05-08
WO1999051188A2 (en) 1999-10-14
PL347946A1 (en) 2002-04-22
KR100638503B1 (ko) 2006-10-26
HUP0102306A1 (hu) 2001-09-28
WO1999051188A9 (en) 2000-10-12
KR20010052244A (ko) 2001-06-25
AU3479799A (en) 1999-10-25
CN1191851C (zh) 2005-03-09
HUP0102306A3 (en) 2008-04-28
JP4739521B2 (ja) 2011-08-03
IL138939A0 (en) 2001-11-25
PL193132B1 (pl) 2007-01-31
CN1342088A (zh) 2002-03-27

Similar Documents

Publication Publication Date Title
DE69532760D1 (de) Mittel zur verabreichung von antigenen
DE69838143D1 (de) Antimikrobielle peptide
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
CA2392756A1 (en) Dna vaccine against staphylococcus aureus
TR200003498T2 (tr) Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları
ATE322503T1 (de) Gefrierschutzprotein
DE69836428D1 (de) Karzinostatische wirkstoffe
GB9219936D0 (en) Vaccines
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
DE69732363D1 (de) HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN
WO1994014976A1 (en) Immune response modulator complex, and uses thereof
ATE442387T1 (de) Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
EE05139B1 (et) Peptiid, seda kodeeriv geen, reagent ja reaktiivikomplekt riketsioosi tuvastamiseks ning peptiidi sisaldav vaktsiin
PT938329E (pt) Composicao de tlp imunogenica
PT773999E (pt) Receptor orfao or-1 pertencente a familia de receptores nucleares
DE68914397D1 (de) Menschliches Lymphotoxin.
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
ATE234358T1 (de) Peptide des pferdearteritisvirus, antikörper und ihre verwendung in einem diagnostischen test
WO2001098355A3 (en) Cgi-69 compositions and methods of use
FI973762A0 (fi) Ny gen
WO2003022867A3 (en) Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli